Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening

The efficiency of COVID-19 mRNA vaccine from Pfizer and Moderna was confirmed in the real world study by using data from vaccinated or non-vaccinated patients who were engaged in healthcare working. Pre-procedural COVID-19 screening revealed that the mRNA vaccination in these healthworkers was effective to reduce the asymptomatic SARS-CoV-2 infection from 3.2% to 1.4%.